Norbert G Riedel - Net Worth and Insider Trading

Norbert G Riedel Net Worth

The estimated net worth of Norbert G Riedel is at least $5 Million dollars as of 2024-11-05. Norbert G Riedel is the Corporate Vice President of Baxter International Inc and owns about 52,815 shares of Baxter International Inc (BAX) stock worth over $2 Million. Norbert G Riedel is the Director of Jazz Pharmaceuticals PLC and owns about 13,705 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $2 Million. Norbert G Riedel is also the Director of ARIAD Pharmaceuticals Inc and owns about 37,000 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $887,630. Besides these, Norbert G Riedel also holds Eton Pharmaceuticals Inc (ETON) , Aptinyx Inc (APTX) . Details can be seen in Norbert G Riedel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Norbert G Riedel has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Norbert G Riedel

To

Norbert G Riedel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Norbert G Riedel owns 6 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , Eton Pharmaceuticals Inc (ETON) , and Aptinyx Inc (APTX) among others .

Click here to see the complete history of Norbert G Riedel’s form 4 insider trades.

Insider Ownership Summary of Norbert G Riedel

Ticker Comapny Transaction Date Type of Owner
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 director
ETON Eton Pharmaceuticals Inc 2018-11-15 director
APTX Aptinyx Inc 2021-12-06 director & CEO and President
LIMIT LIMIT 2017-02-16 director
LIMIT LIMIT 2012-08-03 Corporate Vice President
LIMIT LIMIT 2020-10-27 director

Norbert G Riedel Latest Holdings Summary

Norbert G Riedel currently owns a total of 5 stocks. Among these stocks, Norbert G Riedel owns 52,815 shares of Baxter International Inc (BAX) as of August 3, 2012, with a value of $2 Million and a weighting of 38.51%. Norbert G Riedel owns 13,705 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 14, 2023, with a value of $2 Million and a weighting of 30.84%. Norbert G Riedel also owns 37,000 shares of ARIAD Pharmaceuticals Inc (ARIA) as of May 2, 2011, with a value of $887,630 and a weighting of 17.95%. The other 2 stocks Eton Pharmaceuticals Inc (ETON) , Aptinyx Inc (APTX) have a combined weighting of 12.7% among all his current holdings.

Latest Holdings of Norbert G Riedel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BAX Baxter International Inc 2012-08-03 52,815 36.05 1,903,981
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 13,705 111.28 1,525,092
ARIA ARIAD Pharmaceuticals Inc 2011-05-02 37,000 23.99 887,630
ETON Eton Pharmaceuticals Inc 2018-11-15 59,745 8.33 497,676
APTX Aptinyx Inc 2021-12-06 1,355,873 0.10 130,164

Holding Weightings of Norbert G Riedel


Norbert G Riedel Form 4 Trading Tracker

According to the SEC Form 4 filings, Norbert G Riedel has made a total of 0 transactions in Baxter International Inc (BAX) over the past 5 years. The most-recent trade in Baxter International Inc is the sale of 70,125 shares on August 3, 2012, which brought Norbert G Riedel around $4 Million.

According to the SEC Form 4 filings, Norbert G Riedel has made a total of 4 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,241 shares on August 14, 2023, which brought Norbert G Riedel around $171,457.

According to the SEC Form 4 filings, Norbert G Riedel has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 0 shares on May 2, 2011, which brought Norbert G Riedel around $0.

More details on Norbert G Riedel's insider transactions can be found in the Insider Trading History of Norbert G Riedel table.

Insider Trading History of Norbert G Riedel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Norbert G Riedel Trading Performance

GuruFocus tracks the stock performance after each of Norbert G Riedel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Norbert G Riedel is 15.77%. GuruFocus also compares Norbert G Riedel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Norbert G Riedel within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Norbert G Riedel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Norbert G Riedel

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.05 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Norbert G Riedel Ownership Network

Ownership Network List of Norbert G Riedel

No Data

Ownership Network Relation of Norbert G Riedel

Insider Network Chart

Norbert G Riedel Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Norbert G Riedel is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include SVP & Technical Operations Mary Elizabeth Henderson , VP & Finance& PAO Patricia Carr , and SVP & General Counsel Neena M Patil .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Norbert G Riedel made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Mark Douglas Smith .

In summary, during the past 3 months, insiders sold 1,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 1,410 shares. During the past 18 months, 33,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 21,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Norbert G Riedel Mailing Address

Above is the net worth, insider trading, and ownership report for Norbert G Riedel. You might contact Norbert G Riedel via mailing address: Baxter International Inc, One Baxter Pkwy Df2-1w, Deerfield Il 60015.